02/20/2025 3:05 PM | JOHNSON DAVID LEE (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:07 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:08 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:10 PM | Brenner Robert (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 8:30 AM | Avoro Capital Advisors LLC (Filed by) Vera Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025 7:06 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 3:22 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024 3:24 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 3:59 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 3:05 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 3:40 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for VERA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
11/14/2024 11:15 AM | Kynam Capital Management, LP (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 8:35 AM | Avoro Capital Advisors LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G | |
11/12/2024 9:34 AM | FMR LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 6:49 PM | Longitude Capital Partners IV, LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024 5:05 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 3:15 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/29/2024 5:15 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/28/2024 4:29 PM | Vera Therapeutics (Filer)
| Form S-3ASR | |
10/28/2024 4:30 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 3:37 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 3:16 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024 3:05 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/09/2024 3:17 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024 8:01 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2024 3:05 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 3:45 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:38 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 3:38 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 3:36 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 3:19 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:04 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:40 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 3:31 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:24 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024 3:36 PM | Vera Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2024 4:15 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:30 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 8:27 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Elon’s “New Gold” (Ad) MIT scientists just developed a brand-new metal…
A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology.
It’s so valuable that some are referring to it as the “new gold”. I reveal all of the details here. |
04/05/2024 8:32 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:55 PM | Vera Therapeutics (Filer)
| Form ARS | |
04/03/2024 4:00 PM | Vera Therapeutics (Filer)
| Form DEF 14A | |
04/03/2024 4:02 PM | Vera Therapeutics (Filer)
| Form DEFA14A | |
03/26/2024 7:35 PM | Vera Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:57 PM | Sofinnova Venture Partners X, L.P. (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
03/25/2024 8:46 PM | Katabi Maha (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:54 PM | Katabi Maha (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 6:30 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |